Cite
MLA Citation
Parth Shah et al.. “The expanding capability and clinical relevance of molecular diagnostic technology to identify and evaluate EGFR mutations in advanced/metastatic NSCLC.” Lung cancer, vol. 160, 2021, pp. 118–126. http://access.bl.uk/ark:/81055/vdc_100142214788.0x000047